Edap Tms SA
NASDAQ:EDAP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Advani Hotels and Resorts (India) Ltd
NSE:ADVANIHOTR
|
IN |
Edap Tms SA
Revenue
Edap Tms SA
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Edap Tms SA
NASDAQ:EDAP
|
Revenue
€63.8m
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
9%
|
|
|
Biomerieux SA
PAR:BIM
|
Revenue
€4.1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
8%
|
|
|
Diagnostic Medical Systems SA
PAR:ALDMS
|
Revenue
€46.1m
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
S
|
SMAIO SA
PAR:ALSMA
|
Revenue
€5.5m
|
CAGR 3-Years
37%
|
CAGR 5-Years
70%
|
CAGR 10-Years
N/A
|
|
|
Amplitude Surgical SA
PAR:AMPLI
|
Revenue
€108.5m
|
CAGR 3-Years
12%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Mauna Kea Technologies SA
PAR:ALMKT
|
Revenue
€7.5m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-4%
|
|
Edap Tms SA
Glance View
EDAP TMS SA is a holding company, which through its subsidiary engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. The company is headquartered in Vaulx-En-Velin, Auvergne-Rhone-Alpes and currently employs 227 full-time employees. The firm operates worldwide via an extensive network of corporate offices, subsidiaries and distribution partners. The firm invests in Research & Development, partnering with INSERM French public laboratory and international medical research institutions. Company's activity is organized in two divisions: HIFU and UDS (including lithotripsy activities). The firm is developing HIFU technology (High Intensity Focused Ultrasound) in non-invasive treatment of prostate conditions with its range of Robotic HIFU devices, Ablatherm Fusion and Focal One. The firm is also developing ESWL (Extracorporeal ShockWave Lithotripsy) and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications.
See Also
What is Edap Tms SA's Revenue?
Revenue
63.8m
EUR
Based on the financial report for Sep 30, 2025, Edap Tms SA's Revenue amounts to 63.8m EUR.
What is Edap Tms SA's Revenue growth rate?
Revenue CAGR 10Y
9%
Over the last year, the Revenue growth was 0%. The average annual Revenue growth rates for Edap Tms SA have been 6% over the past three years , 11% over the past five years , and 9% over the past ten years .
